Mindset Intervention Trial for Depression and Immune Response in U.S. Adults

United States data from a 2022-2023 randomized controlled trial with 548 adult participants testing a 'Catastrophes can be Opportunities' mindset intervention. The study measured effects on post-traumatic growth, depression, and immune dysregulation, with a subset providing blood samples at three time points. It includes cohorts for psychological and physiological data collection.

Use Cases

• Analyze intervention effects on depression and self-esteem metrics between the mindset and control groups.
• Model correlations between psychological questionnaire responses and physiological inflammation markers from blood samples.
• Examine post-traumatic growth trajectories using longitudinal data from participants who completed prior COVID-19 surveys.

Strengths

• Data from a randomized controlled trial design with 548 participants, providing a basis for causal inference.
• Includes physiological data from a subset of participants who provided blood samples at three time points.
• Study focuses on a specific, novel intervention targeting post-traumatic growth mindsets post-pandemic.

Limitations

• Sample size of 548 may limit statistical power for detecting smaller effect sizes or subgroup analyses.
• Participants were pre-selected from prior longitudinal surveys, potentially introducing selection bias.
• Lack of column details prevents assessment of data granularity, feature count, and specific variable types.

Provenance

Source

ICPSR Harvested Dataverse, authored by Jesse Barrera.

Collection Method

Randomized controlled trial with participants recruited from previous longitudinal COVID-19 survey cohorts.

Time Range

2022-2023

Freshness

Data last updated on 2026-02-23, indicating recent maintenance.

Geography

United States